VLC-Q

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

Silybum marianum, Quantity: 500 mg (Equivalent: Silybum marianum, Qty 35 g; Equivalent: silymarin, Qty 400 mg); chromic chloride hexahydrate, Quantity: 1.02 mg (Equivalent: chromium, Qty 200 microgram); sugar cane wax alcohols, Quantity: 12 mg; ubidecarenone, Quantity: 50 mg

Available from:

Proudex Australia Pty Ltd

Pharmaceutical form:

Capsule, hard

Composition:

Excipient Ingredients: purified water; titanium dioxide; tartrazine; magnesium stearate; brilliant blue FCF; Gelatin; amaranth; colloidal anhydrous silica; microcrystalline cellulose

Administration route:

Oral

Therapeutic indications:

Antioxidant/Reduce free radicals formed in the body ; Helps reduce/decrease free radical damage to body cells ; Maintain/support natural liver cleansing/detoxification processes ; Maintain/support energy production ; Maintain/support general health and wellbeing ; Helps enhance/promote healthy blood circulation ; Maintain/support healthy blood circulation ; Helps maintain/support healthy cholesterol ; Helps maintain/support healthy blood sugar/glucose ; Maintain/support cardiovascular system health ; Maintain/support heart health ; Hepatoprotectant/protect the liver ; Maintain/support liver health ; Helps stimulate a healthy immune system response ; Aid/assist/helps glucose/sugar/carbohydrate metabolism

Product summary:

Visual Identification: ;

Authorization status:

Listed

Authorization date:

2017-12-15